Heidi Jannenga, COO, WebPT - Jannenga is the co-founder of WebPT, a electronic medical records solution for rehab therapists. As Chief Operating Officer, Heidi leads the product strategy and oversees the WebPT brand vision. She brings with her more than 15 years of experience as a physical therapist and clinic director, and a passion for healthcare innovation and entrepreneurship. WebPT was recently named to the Inc. 500, an elite list of the nation's fastest growing companies.
John Julian, President & CEO, NextCare - Julian has over 20 years of experience successfully operating a wide range of health care services companies including medical equipment, respiratory services, pharmaceuticals, infusion therapy and urgent care. In addition, he has extensive experience in mergers and acquisitions.
Travis Leach, Ballard Spahr - As a practicing attorney, Leach focuses on corporate and securities law, with an emphasis on public offerings, private placements, corporate governance matters, Sarbanes-Oxley and SEC compliance, and mergers and acquisitions. He represents public companies as well as sports and entertainment clients and has been involved in more than $3 billion in corporate transactions, including $250 million in endorsement deals negotiated with Fortune 500 corporations.
Dr. Keith Lindor, Executive Vice Provost and Dean College of Health Solutions, ASU - Dr. Lindor served as the Dean of the Mayo Medical School from 2005-2011 where he was also a Professor of Medicine in the Division of Gastroenterology and Hepatology at the Mayo Clinic College of Medicine in Rochester, Minnesota. Dr. Lindor's interests include cholestatic liver diseases in adults, particularly primary biliary cirrhosis and primary sclerosing cholangitis as well as nonalcoholic steatohepatitis. The focus of his research work is primarily on clinical trials and means of optimizing the medical management of patients with these disorders.
David Schwartz, Office of Business Development, Mayo Clinic - Schwartz's position within Mayo Clinic offers him a unique vantage point. Charged with evaluating, designing and launching strategic ventures, his focus ranges from partnerships to product/service development to supporting an array of broad strategic initiatives. Schwartz is also focused on a mixture of enterprise and Arizona- centric opportunities for Mayo Clinic.
Dr. Ed Staren, President and CEO of Medicine and Science at Cancer Treatment Centers of America (CTCA) & President and CEO, Western Regional Medical Center - An experienced, renowned surgical oncologist, Dr. Staren previously served as senior vice president for Clinical Affairs and chief medical officer for CTCA. Before joining CTCA in 2005, Dr. Staren was senior attending surgeon at the Medical College Hospital in Toledo, Ohio, as well as attending surgeon at both St. Luke's Hospital and Mercy St. Vincent Medical Center.
Marilyn Teplitz, Founder, CEO, MGT Associates - Teplitz leads an international management consultancy, providing product and strategic business consulting to help B2B technology companies enter new markets, extend life of existing products, and define next release product roadmaps. She is focused on healthcare, payers, medical devices, biotech, high tech and software.
John Mascarenas, Director, Intel Capital - Mascarenas joined Intel in 1980 and Intel Capital in 1998 where his focus has included mobility/wireless, embedded, networking and communications. Prior to Intel Capital, he held various positions in engineering, marketing, services and sales. Mascarenas was involved in several Intel technology ventures in Networking Services, Digital Imaging, Cable and Security. Mascarenas holds industrial patents in Digital Imaging. He is a Board Observer in Atempo, Go Ahead, Monosphere, Nirvanix, Wasabi Systems and virtualLogix.
"It's exciting to be a part of an advisory board that has the opportunity to select and further develop smart innovation with the potential to transform the healthcare industry," said John Jullian, president & CEO, NextCare. "NextCare likes Tallwave's approach to reducing risk for investors and commercial partners when they're evaluating investment, acquisition and market development opportunities. Having a view into thoroughly vetted and validated ideas, concepts and early-stage companies gives us a leg up in our own business and corporate development efforts. There is real value in that for us."
Tallwave creates and maximizes commercial success and shareholder value for entrepreneurs and investors by validating, scaling and managing early-stage and growth ventures with a hands-on approach.
((Comments on this story may be sent to firstname.lastname@example.org))